NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology. June 6, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by benzinga. Read more Source: https://www.benzinga.com/pressreleases/26/06/g53025186/nrx-pharmaceuticals-nasdaq-nrxp-notes-presentation-by-osmind-inc-of-iv-ketamine-efficacy-vs-nasal-